Teva presented early clinical feedback from a patient and healthcare professional survey regarding its olanzapine LAI TEV'749 (mdc-TJK), in particular around important schizophrenia treatment factors — dosing schedule, initiation regimen, SC administration, post-injection monitoring requirements an
Avantium: Management team change. Belgian telcos: Extra data on Proximus brand mobile plans at no additional cost. Elia: Launch of €1.35bn rights issue and closing of €850m private placement. Randstad: Preliminary preview of 1Q25F results due 23 April. Shell plc: Very solid CMD, attractive outlook for shareholders. Tessenderlo: 2024 in-line with lowered outlook, soft 2025F guidance
This morning, Avantium announced a series of senior management changes. As such, Boudewijn van Schaïk will step down as CFO (effective from May 2025), with Bert Cornelese taking over as interim CFO from 1 April 2025 until the appointment of a permanent CFO. In parallel, Bram Hoffer, previously serv
EQS-News: TeamViewer SE / Schlagwort(e): Jahresergebnis/Sonstiges TeamViewer veröffentlicht Geschäftsbericht 2024 20.03.2025 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. TeamViewer veröffentlicht Geschäftsbericht 2024 Göppingen, 20. März 2025 – ein weltweit führender Anbieter von Lösungen für Remote Connectivity und die Digitalisierung von Arbeitsprozessen, hat heute seinen Geschäftsbericht 2024 veröffentlicht. In diesem Zusammenhang gab TeamViewer die Ernennung von Jeff Kinder zum neuen Mitglied des Aufsichtsrats bekann...
EQS-News: TeamViewer SE / Key word(s): Annual Results/Miscellaneous TeamViewer Releases Annual Report 2024 20.03.2025 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. TeamViewer Releases Annual Report 2024 GOPPINGEN, Germany, 20 March 2025 - , a leading global provider of remote connectivity and digital workplace solutions, today published its Annual Report 2024. In this context, TeamViewer announced the appointment of Mr. Jeff Kinder as new member of the company’s Supervisory Board. Jeff Kinder succeeds Dr. Jörg Rockenhäuser, who ...
This morning, Avantium announced FY24 results with total income reaching EUR25.6m (+0.6% vs. EUR25.5m in FY23), mainly supported by R&D Solutions and the licence agreement with Origin Materials. The EBITDA loss stood at -EUR33.3m (vs. -EUR27.5m in FY23), slightly better than cons. at -EUR34.4m,
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.